Drug Trial Radar · NCT07686263
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
472
Planned (sponsor's estimate)
Start
Aug 20, 2026
Primary completion
Mar 3, 2029
Study completion Mar 3, 2029
Sponsor
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb companyBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Jul 7, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the relapse prevention of KarXT in the treatment of participants with Schizophrenia
Conditions
- Schizophrenia
Interventions
Xanomeline/Trospium ChlorideDrug
Specified dose on specified days
PlaceboDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time From Randomization to the First Relapse EventTime frame: Up to approximately Week 43
Locations
54 sites in 7 countries. Site status is shown where the registry gives one.
Pillar Clinical Research - Bentonville
Bentonville, Arkansas · Recruiting
Pillar Clinical Research- Little Rock
Little Rock, Arkansas · Recruiting
Local Institution - 0021
Little Rock, Arkansas · Not yet recruiting
Local Institution - 0153
Rogers, Arkansas · Not yet recruiting
Local Institution - 0190
Anaheim, California · Not yet recruiting
Clinical Innovations, Inc. dba CITrials
Bellflower, California · Recruiting
Local Institution - 0032
Culver City, California · Not yet recruiting
Collaborative Neuroscience Research, LLC
Garden Grove, California · Recruiting
Local Institution - 0068
La Habra, California · Not yet recruiting
Local Institution - 0128
Lemon Grove, California · Not yet recruiting
Local Institution - 0187
Montclair, California · Not yet recruiting
NRC Research Institute
Orange, California · Recruiting
Local Institution - 0030
Pico Rivera, California · Not yet recruiting
Local Institution - 0185
Redlands, California · Not yet recruiting
Local Institution - 0186
Riverside, California · Not yet recruiting
Local Institution - 0193
Torrance, California · Not yet recruiting
Health Synergy Clinical Research
Boynton Beach, Florida · Recruiting
Research Centers of America ( Hollywood )
Hollywood, Florida · Recruiting
Local Institution - 0075
Miami, Florida · Withdrawn
Local Institution - 0054
Miami Lakes, Florida · Withdrawn
Local Institution - 0134
Miami Springs, Florida · Withdrawn
Local Institution - 0195
Oakland Park, Florida · Not yet recruiting
Atlanta Center for Medical Research
Atlanta, Georgia · Recruiting
Local Institution - 0070
Sandy Springs, Georgia · Not yet recruiting
Local Institution - 0189
Savannah, Georgia · Not yet recruiting
Local Institution - 0067
Chicago, Illinois · Not yet recruiting
Pillar Clinical Research -Chicago
Chicago, Illinois · Recruiting
Local Institution - 0192
Gaithersburg, Maryland · Not yet recruiting
Local Institution - 0183
Cincinnati, Ohio · Not yet recruiting
Local Institution - 0047
Oklahoma City, Oklahoma · Not yet recruiting
Local Institution - 0049
Austin, Texas · Not yet recruiting
Pillar Clinical Research - Richardson
Richardson, Texas · Recruiting
Local Institution - 0143
Buenos Aires, Argentina · Withdrawn
Local Institution - 0002
Córdoba, Argentina · Not yet recruiting
Local Institution - 0197
Córdoba, Argentina · Not yet recruiting
Clinica El Jardin
Santiago del Estero, Argentina · Recruiting
Local Institution - 0175
Río Cuarto, Córdoba Province, Argentina · Withdrawn
Local Institution - 0191
Novi Iskar, Bulgaria · Not yet recruiting
Local Institution - 0162
Brno, Czechia · Not yet recruiting
Local Institution - 0014
Klecany, Czechia · Not yet recruiting
Showing 40 of 54 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.